Last 12 months
Inside the activity.
0 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 01, 2024 Filed Mar 5, 2024 22:50 UTC |
Countouriotis AthenaDirector
|
GrantDeferred Restricted Stock Unit · Derivative | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-031105 · tm248017d1_4seq1.xml · derivative · entry 1 Countouriotis Athena · CIK 0001571469 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred restricted stock unit ("DRSU") represents a contingent right to receive one share of the Issuer's common stock and are granted pursuant to the Issuer's 2018 Equity Incentive Plan (as amended). F2 · derivative.exercise_date: 50% of the RSUs will vest on the 6-month anniversary of the date of grant and the remaining RSUs will vest on the one-year anniversary of the date of grant. Notwithstanding the vesting, the issuance of the common stock will be deferred until the earlier of (i) three months after the Reported Person's resignation or removal from the Board of Directors or no longer providing service because of death or disability, (ii) a change in control (as defined in the DRSU agreement) or (iii) ten years from the Transaction Date. F2 · derivative.expiration_date: 50% of the RSUs will vest on the 6-month anniversary of the date of grant and the remaining RSUs will vest on the one-year anniversary of the date of grant. Notwithstanding the vesting, the issuance of the common stock will be deferred until the earlier of (i) three months after the Reported Person's resignation or removal from the Board of Directors or no longer providing service because of death or disability, (ii) a change in control (as defined in the DRSU agreement) or (iii) ten years from the Transaction Date. Read SEC document |
| February 20, 2024 Filed Feb 21, 2024 00:52 UTC |
MCPEAK MERRILL ADirector
|
PurchaseCommon Stock | 250,000 | $9.15 | $2,287,500.00 |
DisclosureSEC source: 0001104659-24-025684 · tm246751-1_4seq1.xml · nonDerivative · entry 1 MCPEAK MERRILL A · CIK 0001210317 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 320,150 F2 · shares: Such shares purchased pursuant to Issuer's underwritten offering, which priced on 02/20/2024. F4 · balance_after: Consists of 30,150 shares held in Keogh retirement account plus 40,000 shares as a result of exercised stock options plus 250,000 shares acquired in this offering. Read SEC document |
| February 20, 2024 Filed Feb 20, 2024 21:21 UTC |
Dukes Iain D.Director
|
PurchaseCommon Stock | 32,000 | $9.15 | $292,800.00 |
DisclosureSEC source: 0001104659-24-025539 · tm246751-2_4seq1.xml · nonDerivative · entry 1 Dukes Iain D. · CIK 0001681955 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 54,000 F1 · shares: Such shares purchased pursuant to Issuer's underwritten offering, which priced on 02/20/2024. Read SEC document |
| February 20, 2024 Filed Feb 20, 2024 21:11 UTC |
Rothbaum Wayne P.Director
|
PurchaseCommon Stock | 5,000,000 | $9.15 | $45,750,000.00 |
DisclosureSEC source: 0001104659-24-025520 · tm246751-3_4seq1.xml · nonDerivative · entry 1 Rothbaum Wayne P. · CIK 0001423102 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Quogue Capital LLC Disclosed balance after: 28,067,333 F3 · shares: Such shares purchased pursuant to Issuer's underwritten offering, which priced on 02/20/2024. F2 · balance_after: The numbers reported in column 5 exclude 1,932,667 shares of common stock underlying 1,932,667 shares of Series B Preferred Stock of the Issuer beneficially owned by Quogue Capital LLC. F1 · ownership.nature: Such shares may be held directly by Quogue Capital LLC or are held by one or more entities controlled by Quogue Capital LLC. The reporting person is the sole managing member of Quogue Capital LLC, and therefore, he is deemed to beneficially own such shares of common stock of the Issuer. Read SEC document |
| January 16, 2024 Filed Jan 18, 2024 23:09 UTC |
GRAF FINCKENSTEIN FRIEDRICHChief Medical Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 2,813 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-004865 · tm243610-2_4seq1.xml · derivative · entry 3 GRAF FINCKENSTEIN FRIEDRICH · CIK 0001782981 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,251 Underlying: Common stock · 2,813 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. F5 · derivative.exercise_date: The remaining RSUs will vest in equal quarterly installments. F5 · derivative.expiration_date: The remaining RSUs will vest in equal quarterly installments. Read SEC document |
| January 16, 2024 Filed Jan 18, 2024 23:09 UTC |
GRAF FINCKENSTEIN FRIEDRICHChief Medical Officer
|
Tax withholdingCommon Stock | 1,577 | $8.37 | $13,199.49 |
DisclosureSEC source: 0001104659-24-004865 · tm243610-2_4seq1.xml · nonDerivative · entry 2 GRAF FINCKENSTEIN FRIEDRICH · CIK 0001782981 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,607 F2 · security: Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of the RSUs. This is not an open market sale of securities. F3 · balance_after: Represents the common stock remaining after deducting the common stock withheld for taxes. Read SEC document |
| January 16, 2024 Filed Jan 18, 2024 23:09 UTC |
GRAF FINCKENSTEIN FRIEDRICHChief Medical Officer
|
Exercise / conversionCommon Stock | 2,813 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-004865 · tm243610-2_4seq1.xml · nonDerivative · entry 1 GRAF FINCKENSTEIN FRIEDRICH · CIK 0001782981 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,184 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Represents such shares underlying the restricted stock units ("RSUs") which vested on the transaction date. Read SEC document |
| January 16, 2024 Filed Jan 18, 2024 23:09 UTC |
Vogt Frederick GInterim CEO & General Counsel
|
Exercise / conversionRestricted Stock Units · Derivative | 20,834 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-004866 · tm243610-3_4seq1.xml · derivative · entry 3 Vogt Frederick G · CIK 0001719678 · Interim CEO & General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 83,338 Underlying: Common stock · 20,834 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. F5 · derivative.exercise_date: The remaining RSUs will vest in equal quarterly installments. F5 · derivative.expiration_date: The remaining RSUs will vest in equal quarterly installments. Read SEC document |
| January 16, 2024 Filed Jan 18, 2024 23:09 UTC |
Vogt Frederick GInterim CEO & General Counsel
|
Tax withholdingCommon Stock | 6,530 | $8.37 | $54,656.10 |
DisclosureSEC source: 0001104659-24-004866 · tm243610-3_4seq1.xml · nonDerivative · entry 2 Vogt Frederick G · CIK 0001719678 · Interim CEO & General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 99,138 F2 · security: Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of the RSUs. This is not an open market sale of securities. F3 · balance_after: Represents common stock remaining after deducting the common stock withheld for taxes. Read SEC document |
| January 16, 2024 Filed Jan 18, 2024 23:09 UTC |
Vogt Frederick GInterim CEO & General Counsel
|
Exercise / conversionCommon Stock | 20,834 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-004866 · tm243610-3_4seq1.xml · nonDerivative · entry 1 Vogt Frederick G · CIK 0001719678 · Interim CEO & General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 105,668 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Represents such shares underlying the restricted stock units ("RSUs") which vested on the transaction date. Read SEC document |
| January 16, 2024 Filed Jan 18, 2024 23:07 UTC |
BILINSKY IGORChief Operating Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 2,813 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-004864 · tm243610-1_4seq1.xml · derivative · entry 3 BILINSKY IGOR · CIK 0001594604 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,251 Underlying: Common stock · 2,813 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. F5 · derivative.exercise_date: The remaining RSUs will vest in equal quarterly installments. F5 · derivative.expiration_date: The remaining RSUs will vest in equal quarterly installments. Read SEC document |
| January 16, 2024 Filed Jan 18, 2024 23:07 UTC |
BILINSKY IGORChief Operating Officer
|
Tax withholdingCommon Stock | 1,577 | $8.37 | $13,199.49 |
DisclosureSEC source: 0001104659-24-004864 · tm243610-1_4seq1.xml · nonDerivative · entry 2 BILINSKY IGOR · CIK 0001594604 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,867 F2 · security: Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of the RSUs. This is not an open market sale of securities. F3 · balance_after: Represents common stock remaining after deducting the common stock withheld for taxes. Read SEC document |
| January 16, 2024 Filed Jan 18, 2024 23:07 UTC |
BILINSKY IGORChief Operating Officer
|
Exercise / conversionCommon Stock | 2,813 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-004864 · tm243610-1_4seq1.xml · nonDerivative · entry 1 BILINSKY IGOR · CIK 0001594604 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,444 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Represents such shares underlying the restricted stock units ("RSUs") which vested on the transaction date. Read SEC document |
| October 16, 2023 Filed Oct 19, 2023 00:03 UTC |
GRAF FINCKENSTEIN FRIEDRICHChief Medical Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 2,813 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-109940 · tm2328751-1_4seq1.xml · derivative · entry 3 GRAF FINCKENSTEIN FRIEDRICH · CIK 0001782981 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,064 Underlying: Common stock · 2,813 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F5 · derivative.exercise_date: The remaining RSUs will vest in five equal quarterly installments. F5 · derivative.expiration_date: The remaining RSUs will vest in five equal quarterly installments. Read SEC document |
| October 16, 2023 Filed Oct 19, 2023 00:03 UTC |
GRAF FINCKENSTEIN FRIEDRICHChief Medical Officer
|
Tax withholdingCommon Stock | 1,395 | $3.57 | $4,980.15 |
DisclosureSEC source: 0001104659-23-109940 · tm2328751-1_4seq1.xml · nonDerivative · entry 2 GRAF FINCKENSTEIN FRIEDRICH · CIK 0001782981 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,371 F2 · security: Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of restricted stock units. This is not an open market sale of securities. F3 · balance_after: Represents the common stock remaining after deducting the common stock withheld for taxes. Read SEC document |
| October 16, 2023 Filed Oct 19, 2023 00:03 UTC |
GRAF FINCKENSTEIN FRIEDRICHChief Medical Officer
|
Exercise / conversionCommon Stock | 2,813 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-109940 · tm2328751-1_4seq1.xml · nonDerivative · entry 1 GRAF FINCKENSTEIN FRIEDRICH · CIK 0001782981 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,766 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Represents such shares underlying the restricted stock units ("RSUs") which vested on the transaction date. Read SEC document |
| October 16, 2023 Filed Oct 19, 2023 00:05 UTC |
Vogt Frederick GInterim CEO & General Counsel
|
Exercise / conversionRestricted Stock Units · Derivative | 20,835 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-109942 · tm2328751-3_4seq1.xml · derivative · entry 3 Vogt Frederick G · CIK 0001719678 · Interim CEO & General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 104,172 Underlying: Common stock · 20,835 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F5 · derivative.exercise_date: The remaining RSUs will vest in five equal quarterly installments. F5 · derivative.expiration_date: The remaining RSUs will vest in five equal quarterly installments. Read SEC document |
| October 16, 2023 Filed Oct 19, 2023 00:05 UTC |
Vogt Frederick GInterim CEO & General Counsel
|
Tax withholdingCommon Stock | 8,851 | $3.57 | $31,598.07 |
DisclosureSEC source: 0001104659-23-109942 · tm2328751-3_4seq1.xml · nonDerivative · entry 2 Vogt Frederick G · CIK 0001719678 · Interim CEO & General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 84,834 F2 · security: Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of restricted stock units. This is not an open market sale of securities. F3 · balance_after: Represents common stock remaining after deducting the common stock withheld for taxes. Read SEC document |
| October 16, 2023 Filed Oct 19, 2023 00:05 UTC |
Vogt Frederick GInterim CEO & General Counsel
|
Exercise / conversionCommon Stock | 20,835 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-109942 · tm2328751-3_4seq1.xml · nonDerivative · entry 1 Vogt Frederick G · CIK 0001719678 · Interim CEO & General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 93,685 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Represents such shares underlying the restricted stock units ("RSUs") which vested on the transaction date. Read SEC document |
| October 16, 2023 Filed Oct 19, 2023 00:04 UTC |
BILINSKY IGORChief Operating Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 2,813 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-109941 · tm2328751-2_4seq1.xml · derivative · entry 3 BILINSKY IGOR · CIK 0001594604 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,064 Underlying: Common stock · 2,813 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F5 · derivative.exercise_date: The remaining RSUs will vest in five equal quarterly installments. F5 · derivative.expiration_date: The remaining RSUs will vest in five equal quarterly installments. Read SEC document |
| October 16, 2023 Filed Oct 19, 2023 00:04 UTC |
BILINSKY IGORChief Operating Officer
|
Tax withholdingCommon Stock | 1,395 | $3.57 | $4,980.15 |
DisclosureSEC source: 0001104659-23-109941 · tm2328751-2_4seq1.xml · nonDerivative · entry 2 BILINSKY IGOR · CIK 0001594604 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,631 F2 · security: Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of restricted stock units. This is not an open market sale of securities. F3 · balance_after: Represents common stock remaining after deducting the common stock withheld for taxes. Read SEC document |
| October 16, 2023 Filed Oct 19, 2023 00:04 UTC |
BILINSKY IGORChief Operating Officer
|
Exercise / conversionCommon Stock | 2,813 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-109941 · tm2328751-2_4seq1.xml · nonDerivative · entry 1 BILINSKY IGOR · CIK 0001594604 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,026 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Represents such shares underlying the restricted stock units ("RSUs") which vested on the transaction date. Read SEC document |
| September 18, 2023 Filed Sep 19, 2023 20:30 UTC |
MCPEAK MERRILL ADirector
|
PurchaseCommon Stock | 10,000 | $5.56 | $55,600.00 |
DisclosureSEC source: 0001104659-23-101954 · tm2326424-1_4seq1.xml · nonDerivative · entry 1 MCPEAK MERRILL A · CIK 0001210317 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust Disclosed balance after: 248,633 F1 · ownership.nature: These shares are held by a family trust for which the reporting person is a trustee. Read SEC document |
| September 15, 2023 Filed Sep 15, 2023 22:12 UTC |
Rothbaum Wayne P.Director
|
PurchaseCommon Stock | 5,000,000 | $5.30 | $26,500,000.00 |
DisclosureSEC source: 0001104659-23-101299 · tm2326274-1_4seq1.xml · nonDerivative · entry 1 Rothbaum Wayne P. · CIK 0001423102 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Quogue Capital LLC Disclosed balance after: 23,067,333 F2 · balance_after: The numbers reported in column 5 exclude 1,932,667 shares of common stock underlying 1,932,667 shares of Series B Preferred Stock of the Issuer beneficially owned by Quogue Capital LLC. F1 · ownership.nature: Such shares may be held directly by Quogue Capital LLC or are held by one or more entities controlled by Quogue Capital LLC. The reporting person is the sole managing member of Quogue Capital LLC, and therefore, he is deemed to beneficially own such shares of common stock of the Issuer. Read SEC document |
| July 14, 2023 Filed Jul 17, 2023 22:22 UTC |
GRAF FINCKENSTEIN FRIEDRICHChief Medical Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 2,813 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-081714 · tm2321428-2_4seq1.xml · derivative · entry 3 GRAF FINCKENSTEIN FRIEDRICH · CIK 0001782981 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,877 Underlying: Common stock · 2,813 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F5 · derivative.exercise_date: The remaining RSUs will vest in six equal quarterly installments. F5 · derivative.expiration_date: The remaining RSUs will vest in six equal quarterly installments. Read SEC document |
| July 14, 2023 Filed Jul 17, 2023 22:22 UTC |
GRAF FINCKENSTEIN FRIEDRICHChief Medical Officer
|
Tax withholdingCommon Stock | 1,395 | $7.76 | $10,825.20 |
DisclosureSEC source: 0001104659-23-081714 · tm2321428-2_4seq1.xml · nonDerivative · entry 2 GRAF FINCKENSTEIN FRIEDRICH · CIK 0001782981 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,953 F2 · security: Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of restricted stock units. This is not an open market sale of securities. F3 · balance_after: Represents the common stock remaining after deducting the common stock withheld for taxes. Read SEC document |
| July 14, 2023 Filed Jul 17, 2023 22:22 UTC |
GRAF FINCKENSTEIN FRIEDRICHChief Medical Officer
|
Exercise / conversionCommon Stock | 2,813 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-081714 · tm2321428-2_4seq1.xml · nonDerivative · entry 1 GRAF FINCKENSTEIN FRIEDRICH · CIK 0001782981 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,348 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Represents such shares underlying the restricted stock units ("RSUs") which vested on the transaction date. Read SEC document |
| July 14, 2023 Filed Jul 17, 2023 22:22 UTC |
Vogt Frederick GInterim CEO & General Counsel
|
Exercise / conversionRestricted Stock Units · Derivative | 20,834 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-081715 · tm2321428-3_4seq1.xml · derivative · entry 3 Vogt Frederick G · CIK 0001719678 · Interim CEO & General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 125,007 Underlying: Common stock · 20,834 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F5 · derivative.exercise_date: The remaining RSUs will vest in six equal quarterly installments. F5 · derivative.expiration_date: The remaining RSUs will vest in six equal quarterly installments. Read SEC document |
| July 14, 2023 Filed Jul 17, 2023 22:22 UTC |
Vogt Frederick GInterim CEO & General Counsel
|
Tax withholdingCommon Stock | 8,851 | $7.76 | $68,683.76 |
DisclosureSEC source: 0001104659-23-081715 · tm2321428-3_4seq1.xml · nonDerivative · entry 2 Vogt Frederick G · CIK 0001719678 · Interim CEO & General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 72,850 F2 · security: Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of restricted stock units. This is not an open market sale of securities. F3 · balance_after: Represents common stock remaining after deducting the common stock withheld for taxes. Read SEC document |
| July 14, 2023 Filed Jul 17, 2023 22:22 UTC |
Vogt Frederick GInterim CEO & General Counsel
|
Exercise / conversionCommon Stock | 20,834 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-081715 · tm2321428-3_4seq1.xml · nonDerivative · entry 1 Vogt Frederick G · CIK 0001719678 · Interim CEO & General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 81,701 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Represents such shares underlying the restricted stock units ("RSUs") which vested on the transaction date. Read SEC document |
| July 14, 2023 Filed Jul 17, 2023 22:21 UTC |
BILINSKY IGORChief Operating Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 2,813 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-081713 · tm2321428-1_4seq1.xml · derivative · entry 3 BILINSKY IGOR · CIK 0001594604 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,877 Underlying: Common stock · 2,813 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F5 · derivative.exercise_date: The remaining RSUs will vest in six equal quarterly installments. F5 · derivative.expiration_date: The remaining RSUs will vest in six equal quarterly installments. Read SEC document |
| July 14, 2023 Filed Jul 17, 2023 22:21 UTC |
BILINSKY IGORChief Operating Officer
|
Tax withholdingCommon Stock | 1,395 | $7.76 | $10,825.20 |
DisclosureSEC source: 0001104659-23-081713 · tm2321428-1_4seq1.xml · nonDerivative · entry 2 BILINSKY IGOR · CIK 0001594604 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,213 F2 · security: Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of restricted stock units. This is not an open market sale of securities. F3 · balance_after: Represents common stock remaining after deducting the common stock withheld for taxes. Read SEC document |
| July 14, 2023 Filed Jul 17, 2023 22:21 UTC |
BILINSKY IGORChief Operating Officer
|
Exercise / conversionCommon Stock | 2,813 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-081713 · tm2321428-1_4seq1.xml · nonDerivative · entry 1 BILINSKY IGOR · CIK 0001594604 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,608 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Represents such shares underlying the restricted stock units ("RSUs") which vested on the transaction date. Read SEC document |
| June 06, 2023 Filed Jun 8, 2023 22:20 UTC |
YARNO WENDY LDirector
|
GrantDeferred Restricted Stock Unit · Derivative | 12,988 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-069504 · tm2318216-1_4seq1.xml · derivative · entry 1 YARNO WENDY L · CIK 0001181186 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,988 Underlying: Common Stock · 12,988 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred restricted stock unit ("DRSU") represents a contingent right to receive one share of the Issuer's common stock and are granted pursuant to the Issuer's 2018 Equity Incentive Plan (as amended). F2 · derivative.exercise_date: Provided the Reporting Person continues to be providing service to the Issuer on the following dates, the DRSUs shall vest on the earlier of: (i) the first anniversary of the Transaction Date; or (2) the day prior to the Issuer's next annual shareholder meeting. Notwithstanding the vesting, the issuance of the common stock will be deferred until the earlier of (i) three months after the Reported Person's resignation or removal from the Board of Directors or no longer providing service because of death or disability, (ii) a change in control (as defined in the DRSU agreement) or (iii) ten years from the Transaction Date. F2 · derivative.expiration_date: Provided the Reporting Person continues to be providing service to the Issuer on the following dates, the DRSUs shall vest on the earlier of: (i) the first anniversary of the Transaction Date; or (2) the day prior to the Issuer's next annual shareholder meeting. Notwithstanding the vesting, the issuance of the common stock will be deferred until the earlier of (i) three months after the Reported Person's resignation or removal from the Board of Directors or no longer providing service because of death or disability, (ii) a change in control (as defined in the DRSU agreement) or (iii) ten years from the Transaction Date. Read SEC document |
| June 06, 2023 Filed Jun 8, 2023 22:22 UTC |
Countouriotis AthenaDirector
|
GrantDeferred Restricted Stock Unit · Derivative | 51,955 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-069509 · tm2318216-6_4seq1.xml · derivative · entry 1 Countouriotis Athena · CIK 0001571469 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,955 Underlying: Common Stock · 51,955 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred restricted stock unit ("DRSU") represents a contingent right to receive one share of the Issuer's common stock and are granted pursuant to the Issuer's 2018 Equity Incentive Plan (as amended). F2 · derivative.exercise_date: Provided the Reporting Person continues to be providing service to the Issuer on the following dates, the DRSUs shall vest on the earlier of: (i) the first anniversary of the Transaction Date; or (2) the day prior to the Issuer's next annual shareholder meeting. Notwithstanding the vesting, the issuance of the common stock will be deferred until the earlier of (i) three months after the Reported Person's resignation or removal from the Board of Directors or no longer providing service because of death or disability, (ii) a change in control (as defined in the DRSU agreement) or (iii) ten years from the Transaction Date. F2 · derivative.expiration_date: Provided the Reporting Person continues to be providing service to the Issuer on the following dates, the DRSUs shall vest on the earlier of: (i) the first anniversary of the Transaction Date; or (2) the day prior to the Issuer's next annual shareholder meeting. Notwithstanding the vesting, the issuance of the common stock will be deferred until the earlier of (i) three months after the Reported Person's resignation or removal from the Board of Directors or no longer providing service because of death or disability, (ii) a change in control (as defined in the DRSU agreement) or (iii) ten years from the Transaction Date. Read SEC document |
| June 06, 2023 Filed Jun 8, 2023 22:21 UTC |
MCPEAK MERRILL ADirector
|
GrantDeferred Restricted Stock Unit · Derivative | 51,955 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-069508 · tm2318216-5_4seq1.xml · derivative · entry 1 MCPEAK MERRILL A · CIK 0001210317 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,955 Underlying: Common Stock · 51,955 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred restricted stock unit ("DRSU") represents a contingent right to receive one share of the Issuer's common stock and are granted pursuant to the Issuer's 2018 Equity Incentive Plan (as amended). F2 · derivative.exercise_date: Provided the Reporting Person continues to be providing service to the Issuer on the following dates, the DRSUs shall vest on the earlier of: (i) the first anniversary of the Transaction Date; or (2) the day prior to the Issuer's next annual shareholder meeting. Notwithstanding the vesting, the issuance of the common stock will be deferred until the earlier of (i) three months after the Reported Person's resignation or removal from the Board of Directors or no longer providing service because of death or disability, (ii) a change in control (as defined in the DRSU agreement) or (iii) ten years from the Transaction Date. F2 · derivative.expiration_date: Provided the Reporting Person continues to be providing service to the Issuer on the following dates, the DRSUs shall vest on the earlier of: (i) the first anniversary of the Transaction Date; or (2) the day prior to the Issuer's next annual shareholder meeting. Notwithstanding the vesting, the issuance of the common stock will be deferred until the earlier of (i) three months after the Reported Person's resignation or removal from the Board of Directors or no longer providing service because of death or disability, (ii) a change in control (as defined in the DRSU agreement) or (iii) ten years from the Transaction Date. Read SEC document |
| June 06, 2023 Filed Jun 8, 2023 22:21 UTC |
Maynard Ryan DDirector
|
GrantDeferred Restricted Stock Unit · Derivative | 51,955 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-069507 · tm2318216-4_4seq1.xml · derivative · entry 1 Maynard Ryan D · CIK 0001363984 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,955 Underlying: Common Stock · 51,955 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred restricted stock unit ("DRSU") represents a contingent right to receive one share of the Issuer's common stock and are granted pursuant to the Issuer's 2018 Equity Incentive Plan (as amended). F2 · derivative.exercise_date: Provided the Reporting Person continues to be providing service to the Issuer on the following dates, the DRSUs shall vest on the earlier of: (i) the first anniversary of the Transaction Date; or (2) the day prior to the Issuer's next annual shareholder meeting. Notwithstanding the vesting, the issuance of the common stock will be deferred until the earlier of (i) three months after the Reported Person's resignation or removal from the Board of Directors or no longer providing service because of death or disability, (ii) a change in control (as defined in the DRSU agreement) or (iii) ten years from the Transaction Date. F2 · derivative.expiration_date: Provided the Reporting Person continues to be providing service to the Issuer on the following dates, the DRSUs shall vest on the earlier of: (i) the first anniversary of the Transaction Date; or (2) the day prior to the Issuer's next annual shareholder meeting. Notwithstanding the vesting, the issuance of the common stock will be deferred until the earlier of (i) three months after the Reported Person's resignation or removal from the Board of Directors or no longer providing service because of death or disability, (ii) a change in control (as defined in the DRSU agreement) or (iii) ten years from the Transaction Date. Read SEC document |
| June 06, 2023 Filed Jun 8, 2023 22:21 UTC |
WEISER MICHAELDirector
|
GrantDeferred Restricted Stock Unit · Derivative | 51,955 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-069506 · tm2318216-3_4seq1.xml · derivative · entry 1 WEISER MICHAEL · CIK 0001221449 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,955 Underlying: Common Stock · 51,955 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred restricted stock unit ("DRSU") represents a contingent right to receive one share of the Issuer's common stock and are granted pursuant to the Issuer's 2018 Equity Incentive Plan (as amended). F2 · derivative.exercise_date: Provided the Reporting Person continues to be providing service to the Issuer on the following dates, the DRSUs shall vest on the earlier of: (i) the first anniversary of the Transaction Date; or (2) the day prior to the Issuer's next annual shareholder meeting. Notwithstanding the vesting, the issuance of the common stock will be deferred until the earlier of (i) three months after the Reported Person's resignation or removal from the Board of Directors or no longer providing service because of death or disability, (ii) a change in control (as defined in the DRSU agreement) or (iii) ten years from the Transaction Date. F2 · derivative.expiration_date: Provided the Reporting Person continues to be providing service to the Issuer on the following dates, the DRSUs shall vest on the earlier of: (i) the first anniversary of the Transaction Date; or (2) the day prior to the Issuer's next annual shareholder meeting. Notwithstanding the vesting, the issuance of the common stock will be deferred until the earlier of (i) three months after the Reported Person's resignation or removal from the Board of Directors or no longer providing service because of death or disability, (ii) a change in control (as defined in the DRSU agreement) or (iii) ten years from the Transaction Date. Read SEC document |
| June 06, 2023 Filed Jun 8, 2023 22:20 UTC |
Dukes Iain D.Director
|
GrantDeferred Restricted Stock Unit · Derivative | 103,911 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-069505 · tm2318216-2_4seq1.xml · derivative · entry 1 Dukes Iain D. · CIK 0001681955 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 103,911 Underlying: Common Stock · 103,911 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred restricted stock unit ("DRSU") represents a contingent right to receive one share of the Issuer's common stock and are granted pursuant to the Issuer's 2018 Equity Incentive Plan (as amended). F2 · derivative.exercise_date: Provided the Reporting Person continues to be providing service to the Issuer on the following dates, the DRSUs shall vest on the earlier of: (i) the first anniversary of the Transaction Date; or (2) the day prior to the Issuer's next annual shareholder meeting. Notwithstanding the vesting, the issuance of the common stock will be deferred until the earlier of (i) three months after the Reported Person's resignation or removal from the Board of Directors or no longer providing service because of death or disability, (ii) a change in control (as defined in the DRSU agreement) or (iii) ten years from the Transaction Date. F2 · derivative.expiration_date: Provided the Reporting Person continues to be providing service to the Issuer on the following dates, the DRSUs shall vest on the earlier of: (i) the first anniversary of the Transaction Date; or (2) the day prior to the Issuer's next annual shareholder meeting. Notwithstanding the vesting, the issuance of the common stock will be deferred until the earlier of (i) three months after the Reported Person's resignation or removal from the Board of Directors or no longer providing service because of death or disability, (ii) a change in control (as defined in the DRSU agreement) or (iii) ten years from the Transaction Date. Read SEC document |
| April 18, 2023 Filed Apr 20, 2023 21:43 UTC |
YARNO WENDY LDirector
|
GrantDeferred Restricted Stock Unit · Derivative | 74,823 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-047907 · tm2313348d2_4.xml · derivative · entry 1 YARNO WENDY L · CIK 0001181186 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 74,823 Underlying: Common Stock · 74,823 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred restricted stock unit ("DRSU") represents a contingent right to receive one share of the Issuer's common stock and are granted pursuant to the Issuer's 2018 Equity Incentive Plan (as amended). F2 · derivative.exercise_date: Provided the Reporting Person continues to be providing service to the Issuer on the following dates, the DRSUs shall vest on the earlier of: (i) the first anniversary of the Transaction Date; or (2) the day prior to the Issuer's next annual shareholder meeting. Notwithstanding the vesting, the issuance of the common stock will be deferred until the earlier of (i) three months after the Reported Person's resignation or removal from the Board of Directors or no longer providing service because of death or disability, (ii) a change in control (as defined in the DRSU agreement) or (iii) ten years from the Transaction Date. F2 · derivative.expiration_date: Provided the Reporting Person continues to be providing service to the Issuer on the following dates, the DRSUs shall vest on the earlier of: (i) the first anniversary of the Transaction Date; or (2) the day prior to the Issuer's next annual shareholder meeting. Notwithstanding the vesting, the issuance of the common stock will be deferred until the earlier of (i) three months after the Reported Person's resignation or removal from the Board of Directors or no longer providing service because of death or disability, (ii) a change in control (as defined in the DRSU agreement) or (iii) ten years from the Transaction Date. Read SEC document |
| April 14, 2023 Filed Apr 18, 2023 21:49 UTC |
GRAF FINCKENSTEIN FRIEDRICHChief Medical Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 2,812 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-046843 · tm2313085-2_4seq1.xml · derivative · entry 3 GRAF FINCKENSTEIN FRIEDRICH · CIK 0001782981 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,690 Underlying: Common stock · 2,812 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F5 · derivative.exercise_date: The remaining RSUs will vest in seven equal quarterly installments. F5 · derivative.expiration_date: The remaining RSUs will vest in seven equal quarterly installments. Read SEC document |
| April 14, 2023 Filed Apr 18, 2023 21:49 UTC |
GRAF FINCKENSTEIN FRIEDRICHChief Medical Officer
|
Tax withholdingCommon Stock | 1,395 | $5.64 | $7,867.80 |
DisclosureSEC source: 0001104659-23-046843 · tm2313085-2_4seq1.xml · nonDerivative · entry 2 GRAF FINCKENSTEIN FRIEDRICH · CIK 0001782981 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,535 F2 · security: Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of restricted stock units. This is not an open market sale of securities. F3 · balance_after: Represents the common stock remaining after deducting the common stock withheld for taxes. Read SEC document |
| April 14, 2023 Filed Apr 18, 2023 21:49 UTC |
GRAF FINCKENSTEIN FRIEDRICHChief Medical Officer
|
Exercise / conversionCommon Stock | 2,812 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-046843 · tm2313085-2_4seq1.xml · nonDerivative · entry 1 GRAF FINCKENSTEIN FRIEDRICH · CIK 0001782981 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,930 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: 2,812 of the restricted stock units ("RSUs") issued to the Reporting Person on January 14, 2022 vested and settled on April 14, 2023. Read SEC document |
| April 14, 2023 Filed Apr 18, 2023 21:50 UTC |
Vogt Frederick GInterim CEO & General Counsel
|
Exercise / conversionRestricted Stock Units · Derivative | 20,834 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-046844 · tm2313085-3_4seq1.xml · derivative · entry 3 Vogt Frederick G · CIK 0001719678 · Interim CEO & General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 145,841 Underlying: Common stock · 20,834 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F5 · derivative.exercise_date: The remaining RSUs will vest in seven equal quarterly installments. F5 · derivative.expiration_date: The remaining RSUs will vest in seven equal quarterly installments. Read SEC document |
| April 14, 2023 Filed Apr 18, 2023 21:50 UTC |
Vogt Frederick GInterim CEO & General Counsel
|
Tax withholdingCommon Stock | 8,851 | $5.64 | $49,919.64 |
DisclosureSEC source: 0001104659-23-046844 · tm2313085-3_4seq1.xml · nonDerivative · entry 2 Vogt Frederick G · CIK 0001719678 · Interim CEO & General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60,867 F2 · security: Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of restricted stock units. This is not an open market sale of securities. F3 · balance_after: Represents common stock remaining after deducting the common stock withheld for taxes. Read SEC document |
| April 14, 2023 Filed Apr 18, 2023 21:50 UTC |
Vogt Frederick GInterim CEO & General Counsel
|
Exercise / conversionCommon Stock | 20,834 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-046844 · tm2313085-3_4seq1.xml · nonDerivative · entry 1 Vogt Frederick G · CIK 0001719678 · Interim CEO & General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 69,718 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: 20,834 of the restricted stock units ("RSUs") issued to the Reporting Person on January 14, 2022 vested and settled on April 14, 2023. Read SEC document |
| April 14, 2023 Filed Apr 18, 2023 21:48 UTC |
BILINSKY IGORChief Operating Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 2,812 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-046842 · tm2313085-1_4seq1.xml · derivative · entry 3 BILINSKY IGOR · CIK 0001594604 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,690 Underlying: Common stock · 2,812 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F5 · derivative.exercise_date: The remaining RSUs will vest in seven equal quarterly installments. F5 · derivative.expiration_date: The remaining RSUs will vest in seven equal quarterly installments. Read SEC document |
| April 14, 2023 Filed Apr 18, 2023 21:48 UTC |
BILINSKY IGORChief Operating Officer
|
Tax withholdingCommon Stock | 1,395 | $5.64 | $7,867.80 |
DisclosureSEC source: 0001104659-23-046842 · tm2313085-1_4seq1.xml · nonDerivative · entry 2 BILINSKY IGOR · CIK 0001594604 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,795 F2 · security: Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of restricted stock units. This is not an open market sale of securities. F3 · balance_after: Represents common stock remaining after deducting the common stock withheld for taxes. Read SEC document |
| April 14, 2023 Filed Apr 18, 2023 21:48 UTC |
BILINSKY IGORChief Operating Officer
|
Exercise / conversionCommon Stock | 2,812 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-046842 · tm2313085-1_4seq1.xml · nonDerivative · entry 1 BILINSKY IGOR · CIK 0001594604 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,190 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: 2,812 of the restricted stock units ("RSUs") issued to the Reporting Person on January 14, 2022 vested and settled on April 14, 2023. Read SEC document |
| March 02, 2023 Filed Mar 6, 2023 22:26 UTC |
GRAF FINCKENSTEIN FRIEDRICHChief Medical Officer
|
GrantStock Option (right to buy) · Derivative | 93,750 | $0.00 Strike: $7.12 | $0.00 |
DisclosureSEC source: 0001104659-23-029100 · tm238642-3_4seq1.xml · derivative · entry 2 GRAF FINCKENSTEIN FRIEDRICH · CIK 0001782981 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,750 Underlying: Common Stock · 93,750 shares Expires 2033-03-02 F3 · derivative.exercise_date: Provided the Reporting Person is still employed with the Issuer on the following dates, the options are exercisable as follows: (i) options for the purchase of one-third of such shares shall vest on the one-year anniversary of the date of grant; and (ii) the remaining options shall vest in eight equal quarterly installments over the next two years, commencing with the first quarter following the first anniversary of the date of grant. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.